Search research articles
Contact Us
Filters
Showing results (21-30 of 26) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 26 results.
The Journal of Biological Chemistry
|
November 3, 2016
TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer
Ying-Hui Ko, Marina Domingo-Vidal, Megan Roche, et al.
Nature Communications
|
November 5, 2025
Targeting TAZ-TEAD in minimal residual disease enhances the duration of targeted therapy in melanoma models
Connor A Ott, Timothy J Purwin, Pan-Yu Chen, et al.
Nature Cell Biology
|
August 21, 2023
MacroH2A restricts inflammatory gene expression in melanoma cancer-associated fibroblasts by coordinating chromatin looping
Dan Filipescu, Saul Carcamo, Aman Agarwal, et al.
Cancer Research
|
July 31, 2025
Elevated Transglutaminase-2 in SOX10-Deficient Melanoma Promotes Tumor Onset and Decreases Intratumoral CD4+ T Cells
Signe Caksa, Timothy J Purwin, Dan A Erkes, et al.
Nature Communications
|
March 17, 2022
Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma
Claudia Capparelli, Timothy J Purwin, McKenna Glasheen, et al.
The Journal of Clinical Investigation
|
September 16, 2025
Elevated NR2F1 underlies the persistence of invasive disease after treatment of BRAF-mutant melanoma
Manoela Tiago, Timothy J Purwin, Casey D Stefanski, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 26) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 26 results.
The Journal of Biological Chemistry
|
November 3, 2016
TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer
Ying-Hui Ko, Marina Domingo-Vidal, Megan Roche, et al.
Nature Communications
|
November 5, 2025
Targeting TAZ-TEAD in minimal residual disease enhances the duration of targeted therapy in melanoma models
Connor A Ott, Timothy J Purwin, Pan-Yu Chen, et al.
Nature Cell Biology
|
August 21, 2023
MacroH2A restricts inflammatory gene expression in melanoma cancer-associated fibroblasts by coordinating chromatin looping
Dan Filipescu, Saul Carcamo, Aman Agarwal, et al.
Cancer Research
|
July 31, 2025
Elevated Transglutaminase-2 in SOX10-Deficient Melanoma Promotes Tumor Onset and Decreases Intratumoral CD4+ T Cells
Signe Caksa, Timothy J Purwin, Dan A Erkes, et al.
Nature Communications
|
March 17, 2022
Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma
Claudia Capparelli, Timothy J Purwin, McKenna Glasheen, et al.
The Journal of Clinical Investigation
|
September 16, 2025
Elevated NR2F1 underlies the persistence of invasive disease after treatment of BRAF-mutant melanoma
Manoela Tiago, Timothy J Purwin, Casey D Stefanski, et al.
Page
of 3